ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Skyrizi 150mg, Injektionslösung im Fertigpen - 
68118001 AbbVie AG
Skyrizi 150mg, Injektionslösung im Fertigpen07.07.2021
  07.07.2021
Risankizumab (L04AC18) 
WHO-DDD06.07.2026
07.15. 
07.15. 
B  
Yes 
IPCI
3085.45Yes
    
10 %3372.05
  
7680681180012Biotechnologika
  
Composition
risankizumabum 150 mg, natrii acetas trihydricus corresp. natrium 0.209 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 1 ml.
Packungsbestandteile
Injektionslösung im Fertigpen 
  
 
Active AgentDose
Risankizumabum150 mg/ml
BAG: Active AgentDose
Risankizumabum150 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home